Atlas Trials

Delayed Versus Immediate Use Of Zoledronic Acid For Postmenopausal Patients With Early Breast Cancer Who Are Using Adjuvant Letrozole

Clinical trial NCT05164952 · UNKNOWN

Trial details

NCT number
NCT05164952
Sponsor
Assiut University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Use of Zoledronic Acid in Breast Cancer
Start date
2021-09-30
Primary completion
2023-08-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.